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Two murine monoclonal antibodies (MAbs) (2B7 and 46E9-9) reactive with the H7 flagellar antigen of
Escherichia coli were produced and characterized. A total of 217 E. coli strains (48 O157:H7, 4 O157:NM, 23
O157:non-H7, 22 H7:non-O157, and 120 non-O157:non-H7), 17 Salmonella serovars, and 29 other gramnegative bacteria were used to evaluate the reactivities of the two MAbs by indirect enzyme-linked immunosorbent assay (ELISA). Both MAbs reacted strongly with all E. coli strains possessing the H7 antigen and with
H23- and H24-positive E. coli strains. Indirect ELISA MAb specificity was confirmed by inhibition ELISA and
by Western blotting (immunoblotting), using partially purified flagellins from E. coli O157:H7 and other E. coli
strains. On a Western blot, MAb 46E9-9 was more reactive against H7 flagellin of E. coli O157:H7 than against
H7 flagellin of E. coli O1:K1:H7. Competition ELISA suggested that MAbs 2B7 and 46E9-9 reacted with closely
related H7 epitopes. When the ELISA reactivities of the MAbs and two commercially available polyclonal
anti-H7 antisera were compared, both polyclonal antisera and MAbs reacted strongly with E. coli H7 bacteria.
However, the polyclonal antisera cross-reacted strongly both with non-H7 E. coli and with many non-E. coli
bacteria. The polyclonal antisera also reacted strongly with H23 and H24 E. coli isolates. The data suggest the
need to define serotype-specific epitopes among H7, H23, and H24 E. coli flagella. The anti-H7 MAbs described
in this report have the potential to serve as high-quality diagnostic reagents, used either alone or in combination with O157-specific MAbs, to identify or detect E. coli O157:H7 in food products or in human and
veterinary clinical specimens.
protein of E. coli O157:H7 and O26:H11 have also been produced and utilized for E. coli O157:H7 detection (14, 18, 25,
26). Since many nonpathogenic E. coli O157:non-H7 isolates
are known, detection of the O157 antigen independent of the
H7 antigen is insufficient for E. coli O157:H7 identification.
However, some studies of pathogenic E. coli have identified
field isolates as belonging to the O157 serotype without determining the H serotype and assumed that the flagellar serotype
was H7 (10). In many other field and clinical studies, the
services of a reference laboratory were required for H serotyping, since there is currently no easy method to confirm the
presence or absence of H7 on E. coli isolates. No anti-H7
MAbs are currently available to our knowledge. In this article,
the production and characterization of two MAbs reactive with
the H7 antigen of E. coli are described. These MAbs have the
potential to be used alone or in combination with O157-specific antibodies to accurately identify E. coli O157:H7 in food
and clinical specimens.

Escherichia coli O157:H7 was first identified as a human
pathogen and cause of hemorrhagic colitis in the United States
in 1982 (32). Many cases and outbreaks of hemorrhagic colitis
and hemolytic uremic syndrome have been associated with E.
coli O157:H7 infections since then (1–3, 8, 9, 15–17, 21, 31, 33,
37, 38). Food products contaminated with E. coli O157:H7
have commonly been identified as the source of infection (15,
27). Therefore, the development of reagents and methods to
detect E. coli O157:H7 in food products and in clinical medicine specimens has recently been the focus of much research.
While several methods have been developed to detect and
isolate E. coli O157:H7 (27), there is currently no simple,
rapid, and accurate technique suitable for routine use by clinical medicine or food microbiology laboratories. A major limiting factor for E. coli O157:H7 detection has been the lack of
high-quality immunodiagnostic reagents.
E. coli O157:H7 bacteria contain specific O polysaccharide
(O157) and flagellar protein (H7) antigens. Therefore, the
production of monoclonal antibodies (MAbs) against unique
epitopes on the O157 and H7 antigens is a logical approach to
generate useful immunodiagnostic reagents for sensitive and
specific identification of E. coli O157:H7. Polyclonal (23, 24,
36) and monoclonal (30, 35) antibodies against the O157 antigen have been produced and used to screen for E. coli O157:
H7. MAbs against verotoxins VT-I and VT-II (28, 29, 34) of
enterohemorrhagic E. coli and against an outer membrane

MATERIALS AND METHODS
Bacterial strains. E. coli O157:H7 strain ATCC 43895 (American Type Culture Collection, Rockville, Md.) was used for mouse immunization for hybridoma production and as the positive-control antigen for MAb screening. Additional bacteria used to characterize MAb reactivity included 47 other E. coli
O157:H7 strains, 4 E. coli O157:NM strains, 23 E. coli O157:non-H7 strains, 22
E. coli H7:non-O157 strains, 73 non-O157:non-H7 E. coli strains, 17 Salmonella
serovars, and 29 other gram-negative bacteria. Isolates were either purchased
from the American Type Culture Collection or generously provided by the
Centers for Disease Control and Prevention (Atlanta, Ga.), the National Animal
Disease Center (Ames, Iowa), the National Veterinary Services Laboratories
(Ames, Iowa), the E. coli Reference Center (ECRC; Pennsylvania State University, University Park, Pa.), and South Dakota State University (Brookings,
S.Dak.). In addition, 47 E. coli isolates representing flagellum serotypes H1 to
H56 were provided by the ECRC. A detailed list of all bacterial isolates (strain,
description, and source) is available upon request.

* Corresponding author. Mailing address: USDA, ARS, U.S. Meat
Animal Research Center, P.O. Box 166, Clay Center, NE 68933.
Phone: (402) 762-4180. Fax: (402) 762-4375. Electronic mail address:
he@aux.marc.usda.gov.
† Present address: Omaha College of Health Careers, Omaha, NE
68154.
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Anti-H7 polyclonal sera. Anti-H7 polyclonal rabbit sera were purchased from
Difco Laboratories (Detroit, Mich.) and also provided by the ECRC.
Partial purification of E. coli flagellin. Bacteria were grown and selected for
motility by the methods of Fujita et al. (7) with modifications. Bacterial stock in
Trypticase soy broth was inoculated into flagellum broth (2% buffered peptone
water, 1% beef extract, 0.5% glucose; Difco Laboratories) and incubated in an
orbital shaker for 6 to 8 h at 378C. A loop of this culture was then stabbed into
the center of a semisolid nutrient agar (flagellum broth–0.30% agar–8% gelatin;
Difco Laboratories) plate (150 by 15 mm). Bacteria were then grown overnight
at 378C with the plates positioned at a slight incline in the incubator. A sterile
loop was used to cut and lift out a strip (5 by 10 mm) of agar at the leading edge
of the bacterial growth ring on the elevated (antigravity) edge of the plate. This
agar strip containing heavy bacterial growth was placed into flagellum broth and
incubated overnight at 378C. The bacteria were harvested by centrifugation at
15,000 3 g for 1 h at 48C, and the cell pellet was suspended in ice-cold 20 mM
Tris buffer, pH 7.4. The cell suspension was then homogenized twice in a Waring
blender (to remove flagellar filaments from the cell surface) for 2.5 min on ice,
with a 5-min rest in between. The resultant homogenate was centrifuged at
10,000 3 g for 30 min at 48C, and the supernatant was collected. The flagellar
proteins in the supernatant were then pelleted at 100,000 3 g for 3 h at 48C. The
pellet was resuspended in phosphate-buffered saline (PBS) and stored at 2208C
until use.
Whole-bacterium antigen preparation. E. coli was grown in flagellum broth
and then on semisolid nutrient agar, as described above. Bacteria from the
leading growth edge on the elevated side of the nutrient agar plate were inoculated into flagellum broth and incubated overnight at 378C. This culture was
then used to inoculate the entire surface of Trypticase soy agar plates. After
overnight incubation at 378C, the bacteria from each plate were loop harvested,
diluted in 1 ml of deionized distilled water, heat inactivated (1 h at 608C), and
sonicated on ice for 10 min (1-min rest between strokes). Non-E. coli bacteria
were plated on Trypticase soy agar, incubated overnight at 378C, loop harvested,
diluted in 1 ml of deionized distilled water, heat inactivated, and sonicated.
Whole-bacterium antigens were stored frozen at 2208C until use.
Immunization of mice. The whole-bacterium antigen suspension of E. coli
O157:H7 ATCC 43895 was mixed with adjuvant (monophosphoryl lipid A and
trehalose dicorynomycolate emulsion; Ribi ImmunoChem Research Inc., Hamilton, Mont.) (20 mg/0.2 ml) according to the manufacturer’s protocol. Four
BALB/c mice (about 8 weeks old) were intraperitoneally (i.p.) injected with 0.2
ml of the bacterial-antigen emulsion. The mice were boosted with partially
purified flagellin (20 mg per mouse) of E. coli O157:H7 without adjuvant by three
i.p. injections over a 2-week interval. The final i.p. injection of the partially
purified flagellin (20 mg per mouse) was given 4 days before fusion.
Fusion and hybridoma production. Fusion and hybridoma production were
performed by the methods of Hockfield et al. (13). Spleen cells from an immunized mouse were fused with X63Ag8.653 mouse myeloma cells (American Type
Culture Collection) in serum-free Dulbecco’s modified Eagle medium (Gibco
BRL, Grand Island, N.Y.) by using 50% polyethylene glycol (molecular weight,
1,450) (Sigma Chemical Company, St. Louis, Mo.). Fused cells were resuspended
in hypoxanthine-aminopterin-thymidine medium (Dulbecco’s modified Eagle
medium with 10% myeloma cell cultured medium, 10% mouse macrophage
cultured medium, 10% hybridoma cloning factor [Fisher Scientific, St. Louis,
Mo.], 15% fetal bovine serum, antibiotics, and hypoxanthine-aminopterin-thymidine).
Cloning and subcloning of hybridomas. Mouse peritoneal macrophages were
harvested by peritoneal lavage (13). The central 60 wells of 96-well plates
(Costar, Cambridge, Mass.) were filled with hypoxanthine-aminopterin-thymidine medium containing the macrophages (5 3 103 per well) and cultured for 1
to 2 days in a 378C incubator with 8.6% CO2. The hybridoma cells were added
to the macrophage feeder layers and cultured in the 8.6% CO2 incubator for
about 2 weeks at 378C, until the clones were large enough for ELISA screening.
Hybridomas with desirable reactivity on screening by ELISA were subcloned two
or three times by limiting dilution at 0.5 cell per well (13).
Ascites fluid production. A group of retired breeder BALB/c mice was given
0.1 ml pristane (Sigma Chemical Company) by i.p. injection. After a 5- to 7-day
rest period, the mice were injected with 1.0 ml of the hybridoma cell suspension
(107 cells) in serum-free Dulbecco’s modified Eagle medium by i.p. injection.
Ascites fluid containing the MAbs was collected beginning 1 week after the cell
injection.
MAb isotyping. An antibody isotyping kit (Calbiochem-Novabiochem Corporation, La Jolla, Calif.) was used with minor modifications. Enzyme-linked immunosorbent assay (ELISA) microtiter plates were coated with rabbit antibodies
against each mouse immunoglobulin (Ig) isotype for 2 h at 378C, and culture
medium or diluted ascites fluid was then added to the plate wells. After the plates
were incubated and washed, peroxidase-labeled antibodies to mouse IgG1,
IgG2a, IgG2b, IgG3, IgA, and IgM were added to the wells, and the samples
were reacted with substrates as described under “Indirect ELISA.”
Purification and labeling of MAbs. IgG MAbs were purified by affinity chromatography (Affi-Gel protein A MAPS II kit; Bio-Rad, Hercules, Calif.). MAbs
were coupled to horseradish peroxidase (HRPO; Sigma Chemical Company) by
the periodate method (11).
Indirect ELISA. A modification of a rapid indirect ELISA procedure (22) was
used in this study. Ninety-six-well flexible polyvinyl chloride microtiter plates
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(Dynatech, Chantilly, Va.) were coated with whole-bacterium antigens (50 mg/
ml, 100 ml per well) or partially purified flagellins (10 mg/ml, 100 ml per well) and
diluted in a coating buffer (15 mM Na2CO3–35 mM NaHCO3 [pH 9.6]). After
being covered with seal tape, the plates were incubated for 2 h at 378C. Coated
plates were either used immediately or stored at 2208C until use.
The antigen-coated plates were first washed eight times with wash buffer
(0.923% FTA hemagglutination buffer powder [Becton Dickinson, Cockeysville,
Md.], 0.1% Tween 80, 0.5% sterile filtered horse serum). The hybridoma culture
media or diluted (1:1,000) ascites fluid and controls (hypoxanthine-aminopterinthymidine medium, normal mouse serum [1:2,000 in wash buffer], and postimmunization serum from the mouse used for fusion [1:2,000 in wash buffer, 100
ml]) were added to wells. The plates were then incubated for 10 min at 378C.
After eight washes, HRPO-labeled antibody to mouse IgG and IgM (heavy plus
light chains) (Kirkegaard & Perry Laboratories [KPL], Gaithersburg, Md.) (diluted 1:2,000 with wash buffer, 100 ml) was added to each well, and the plates
were incubated for another 10 min. After eight washes, 100 ml of a substrate
solution (0.017% H2O2, 0.001% 2,29-azino-bis [3-ethylbenzthiazoline-6-sulfonic
acid] [ABTS; Sigma Chemical Company] solution in citrate buffer [50 mM citric
acid, pH 4.0]) was added to each well. The optical density (OD) of the blue-green
color reaction was measured with an automated ELISA reader through a 405-nm
filter 20 min after the addition of the substrate solution. An indirect ELISA using
commercial anti-H7 polyclonal sera was identical to the above procedure with
two exceptions: (i) rabbit anti-H7 antiserum was diluted at 1:2,000 (ECRC
antisera) or at 1:8,000 (antisera from Difco Laboratories), and (ii) HRPOconjugated goat anti-rabbit IgG (KPL) at 1:2,000 was used as the second ELISA
antibody.
Inhibition ELISA. A modification of a previously described procedure was
used (4). Partially purified flagellins were twofold serially diluted with sterile
physiological saline in 96-well plates (Costar). The MAbs (either in culture
media or in diluted [1:1,000] ascites solution) were mixed with equal volumes of
different diluted antigens in 96-well plates. After incubation for 30 min at 378C,
the mixtures were transferred (100 ml) in duplicate to the E. coli O157:H7
whole-bacterium antigen-coated plates as described under “Indirect ELISA.”
The plates were incubated for 10 min at 378C. The rest of the procedures were
followed as described under “Indirect ELISA.”
Competition ELISA. Unlabeled MAb was serially twofold diluted with PBS
and incubated for 1 h at 378C on an ELISA plate coated with partially purified
E. coli O157:H7 flagellin (10 mg/ml, 100 ml per well). After aspiration and
washing (as described under “Indirect ELISA”), an HRPO-conjugated test MAb
at a constant concentration was added to the wells for 10 min at 378C. ABTS was
used as substrate. The presence or absence of competition of the MAb with the
test MAb was revealed by the change in the OD (405 nm) at various concentrations of the MAb.
Western blotting assay. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting (immunoblotting) procedures were
performed as previously described (12) with minor modifications. Partially purified flagellins from different bacteria or whole-bacterium antigens were loaded
onto three discontinuous SDS-polyacrylamide (4% stacking and 10% separating)
gels. After electrophoresis, one gel was stained with Coomassie brilliant blue,
and the antigens in two other gels were transferred onto polyvinylidene fluoride
membranes. The membranes were blocked with 3% bovine serum albumin in a
wash buffer (150 mM NaCl, 0.05% Nonidet P-40, 1 mM EDTA, 50 mM Tris [pH
7.4]) for 1 h and then probed with the hybridoma culture media or diluted
(1:1,000) ascites fluid for 1 h at room temperature. The HRPO-conjugated rabbit
anti-mouse IgG-IgM antibody (1:1,000; see “Indirect ELISA”) was used as the
second antibody. The substrate diaminobenzidine (KPL) was used to visualize
the specific bands. Assays were repeated three times.

RESULTS
Production of MAbs. Approximately 3,000 hybridoma clones
resulted from one fusion; of these, 320 clones showed positive
reactions to E. coli O157:H7 (OD . 0.2) and negative reactions to E. coli O78:H11 (OD , 0.05) by indirect ELISA on
initial screening. Subsequent ELISA screening with 168 other
bacteria identified two clones (2B7 and 46E9-9) which were
reactive against the E. coli H7 antigen. Both MAbs 2B7 and
46E9-9 were identified as IgG1 isotype.
Specificities of MAbs. After subcloning, the MAbs in hybridoma supernatant (culture media) or in diluted (1:1,000) ascites
fluid were tested against a large panel of gram-negative bacteria by ELISA as summarized in Table 1. Both MAbs reacted
strongly with 48 of 48 E. coli O157:H7 isolates, 22 of 22 E. coli
H7:non-O157 isolates, 2 of 2 E. coli O45:H23 isolates, and 2 of
2 E. coli O51:H24 isolates. Neither MAb reacted with any of
the following bacteria: four E. coli O157:NM isolates, 23 E. coli
O157:non-H7 isolates, 69 E. coli non-O157:non-H7 isolates, 17
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TABLE 1. ELISA reactivities of MAbs 2B7 and 46E9-9 to 216
whole-bacterium antigens
Bacterium(-a) [n]

No. positivesa

E. coli
O157:H7 [48] ............................................................................. 48
O157:NM [4].............................................................................. 0
H7:non-O157 [22]...................................................................... 22
O157:non-H7 [23]...................................................................... 0
Non-O157:non-H7 [69]............................................................. 0
O45:H23 [2] ............................................................................... 2
O51:H24 [2] ............................................................................... 2
Salmonella spp.b [17]..................................................................... 0
Other gram-negative bacteriac [29]............................................. 0
OD at 405 nm . 0.100. The two MAbs produced the same results.
S. arizonae, S. choleraesuis, S. dublin (n 5 3), S. enteritidis, S. godesberg type
O:30, S. landau, S. mbandaka (n 5 3), S. newport, S. soerenga, S. typhimurium
(n 5 2), S. urbana type O:30, and one untypeable Salmonella sp.
c
Actinobacillus suis, Aeromonas hydrophilia, Alcaligenes faecalis, Bordetella brochiseptica, Brucella abortus (n 5 3), Cedecea lapagei, Citrobacter freundii, Escherichia hermannii, Edwardsiella tarda, Enterobacter cloacae, Haemophilus sommus,
Hafnia alvei, Klebsiella pneumoniae, Leminorella grimontii, Pasteurella haemolytica, Pasteurella multocida (n 5 2), Proteus vulgaris, Providencia stuartii, Pseudomonas aeruginosa, Pseudomonas maltophilia, Serratia marcescens, Shigella sonnei,
Yersinia enterocolitica (n 5 3), Yersinia pseudotuberculosis.
a
b
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Salmonella serovars, and 29 other gram-negative bacteria. The
comparative ELISA reactivities of the two MAbs (in diluted
[1:1,000] ascites fluid) and the two commercial H7 polyclonal
antisera against various whole-bacterium antigens are shown
graphically in Fig. 1. Both polyclonal anti-H7 sera reacted with
all 48 O157:H7 and 22 H7-non-O157 E. coli strains. However,
unlike the MAbs, the polyclonal sera also reacted strongly in
ELISA with many non-H7 E. coli and non-E. coli bacteria.
Dilution of polyclonal sera reduced this cross-reactivity but
also simultaneously decreased polyclonal reactivity with H7positive E. coli strains (data not shown).
Specificities of the MAbs were further examined with partially purified E. coli flagellins and E. coli O157 lipopolysaccharide (LPS). ELISA plates were coated with partially purified E. coli flagellins (10 mg/ml) from E. coli O157:H7, O1:K1:
H7, O45:H23, O51:H24, and O157:H52; whole-bacterium
antigens (50 mg/ml) from E. coli O157:H7 and O78:H11; and
phenol-water-purified LPS from E. coli O157:H7. Indirect
ELISA reactivities of the MAbs against these different bacterial components were then compared. As shown in Fig. 2,
MAbs 2B7 and 46E9-9 reacted similarly with E. coli O157:H7
whole-bacterium antigens and with the partially purified flagellins of E. coli O157:H7, O1:K1:H7, O45:H23, and O51:H24.
However, neither MAb 2B7 nor MAb 46E9-9 reacted with E.
coli O157:H52 flagellin or O157:H7 LPS. As an MAb negative

FIG. 1. Comparative ELISA reactivities of two anti-H7 MAbs and two commercial anti-H7 polyclonal antisera to different bacterial antigens. ELISA plates were
coated with whole-bacterium antigens of bacteria (50 mg/ml, 100 ml per well). The diluted murine ascites fluid of MAbs 2B7 and 46E9-9 (1:1000) and the rabbit anti-H7
antisera from ECRC (1:2,000) and Difco Laboratories (1:8,000) were incubated with the antigens (100 ml/well). HRPO-conjugated antibodies to mouse IgG and IgM
and to rabbit IgG (KPL) were diluted at 1:2,000. The data are means with standard deviations. p, see Table 1.
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FIG. 2. ELISA reactivities of MAbs 2B7 and 46E9-9 against E. coli O157:H7 whole bacteria, partially purified flagellins, and partially purified O157 LPS.
Ninety-six-well ELISA plates were coated with whole-bacterium antigens (WBA) (50 mg/ml) of E. coli O157:H7, partially purified flagellins (10 mg/ml) of different
bacteria, and water-phenol-purified E. coli O157:H7 LPS. Hybridoma supernatant containing the MAbs was incubated with the antigens in duplicate for 10 min at 378C.
HRPO-conjugated rabbit anti-mouse IgG and IgM (heavy plus light chains) was used as the secondary antibody, and ABTS substrate was used as the indicator. The
data are means for duplicate wells.

control, an anti-O157 LPS-specific MAb (MAb 51B2) was included in these ELISAs. MAb 51B2 reacted strongly only with
E. coli O157 LPS, E. coli O157:H7 whole-bacterium antigens,
and partially purified E. coli O157:H7 flagellin. Neither MAb
reacted with the whole-bacterium antigen from E. coli O78:
H11 (negative-control antigen).
Antigenic specificities of the MAbs were studied by inhibition ELISA. If the inhibiting antigen shares the epitope with
the target antigen, the incubation of the inhibiting antigen with
the MAb should decrease the capability of the MAb to bind to
the target antigen. As shown in Fig. 3, E. coli O157:H7 flagellin
displayed the highest inhibition of the binding capability of
MAbs 2B7 and 46E9-9. Flagellins of E. coli O1:K1:H7, O45:
H23, and O51:H24 exhibited similar levels of inhibition of the
binding of MAb 2B7 to E. coli O157:H7. The flagellin of E. coli
O1:K1:H7 had greater inhibitory effect than flagellins of E. coli
O45:H23 and O51:H24 on the binding of MAb 46E9-9 to E.
coli O157:H7. All inhibition reactions showed concentration
dependence. The flagellins of E. coli O157:H16, O157:H52,
and O78:H11 had no inhibitory effect on the binding activities
of the MAbs to E. coli O157:H7 antigens.
Immunoblotting confirmed the specificities of MAbs 2B7
and 46E9-9, as shown in Fig. 4. The same amounts (2 mg) of
partially purified flagellins from E. coli O157:H7, O157:H16,
O1:K1:H7, O45:H23, O51:H24, and O157:H52 and whole-bacterium antigens (12.5 mg) of E. coli O157:H7, O78:H11, and
O157:NM were loaded in three identical SDS-polyacrylamide
gels. The protein profile of the different preparations in the
discontinuous SDS-polyacrylamide gel was revealed by Coomassie brilliant blue staining (Fig. 4A). The H7 antigens from

E. coli O157:H7 and O1:K1:H7 (lanes 1 and 3), H23 (lane 4),
and H24 (lane 5) had the same molecular masses of approximately 65 kDa. H52 (lane 6) and H16 (lane 2) had molecular
masses of about 63 and 56 kDa, respectively. MAb 2B7 (Fig.
4B) reacted with the purified flagellins of E. coli O157:H7 and
O1:K1:H7 (lanes 1 and 3), H23 (lane 4), and H24 (lane 5), as
well as the E. coli O157:H7 whole-bacterium antigen (lane 7),
but did not react with H16 (lane 2) and the other two bacterial
(O78:H11 and O157:NM) antigens (lanes 8 and 9). MAbs 2B7
appeared to have a stronger reaction to the purified flagellin of
E. coli O157:H7 than other reactive flagellins. Interestingly,
MAb 46E9-9 (Fig. 4C) appeared much more reactive on Western blot to the H7 antigen from E. coli O157:H7 (lanes 1 and
7) and showed only weak reactions to H7 from E. coli O1:K1:
H7, H23, and H24 (lanes 3 to 5). At least two bands were
visible (63 and 65 kDa) in the E. coli O157:H7 whole-bacterium antigen preparation (lane 7), detected by MAbs 2B7 and
46E9-9 (Fig. 4B and C), with a stronger reaction occurring to
the lower-molecular-weight band (63 kDa). However, only the
higher-molecular-weight band (65 kDa) (lane 1) was visible
when the partially purified flagellin of E. coli O157:H7 was the
antigen.
Competition ELISA permitted study of epitope specificities
of the anti-H7 MAbs. Preincubation of a MAb with the target
antigens before the test MAb will decrease binding of the test
MAb to the antigens. This results in lower ELISA OD values
in the presence of competition if both MAbs react with the
same or closely related epitopes. As shown in Fig. 5, the 50%
homologous competition dose of MAbs 2B7 and 46E9-9 was
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FIG. 4. SDS-PAGE and Western blots of MAbs 2B7 and 46E9-9. Partially
purified flagellins (2 mg per well) of E. coli O157:H7, O157:H16, O1:K1:H7,
O45:H23, O51:H24, and O157:H52 (lanes 1 to 6, respectively) and whole-bacterium antigens (12.5 mg per well) of E. coli O157:H7, O78:H11, and O157:NM
(lanes 7 to 9, respectively) were run in discontinuous SDS-PAGE. MAb culture
medium or diluted (1:1,000) ascites fluid of 2B7 (B) or 46E9-9 (C) was used as
the first antibody. Specific bands were revealed with HRPO-conjugated rabbit
anti-mouse IgG-IgM antibody (KPL; 1:2,000) and DAB substrate (KPL). (A)
Coomassie brilliant blue-stained protein gel identical to that used for immunoblotting in panels B and C. MW, molecular weight markers.

FIG. 3. Inhibition ELISA for MAbs 2B7 and 46E9-9. ELISA plates were
coated with whole-bacterium antigens of E. coli O157:H7 (50 mg/ml). MAbs in
diluted (1:1,000) ascites fluid were mixed equally (vol/vol) with twofold serially
diluted inhibiting antigens and incubated for 1 h at 378C. The mixtures were
added to duplicate wells of ELISA plates coated with E. coli O157:H7. MAb
reactivities to E. coli O157:H7 are expressed as mean ODs at 405 nm, after use
of the HRPO-conjugated rabbit anti-mouse IgG and IgM (heavy plus light
chains) and the substrate ABTS. The symbols represent the inhibiting antigens,
which were partially purified H antigens: h, O157:H7; ■, O1:K1:H7; {, O45:
H23; Ç, O51:H24; å, O78:H11; }, O157:H16; E, O157:H52.

about 30 mg/ml. Heterologous competitions between 2B7 and
46E9-9 were very similar to the homologous competitions.
Specificity comparison of the MAbs and polyclonal anti-H7
sera against E. coli H serotypes. A panel of E. coli strains
representing 47 different H serotypes (from H1 to H56), in
addition to 18 E. coli O157:H7 isolates and 11 H7:non-O157
strains, were used to compare the ELISA reactivities of the two
MAbs and two polyclonal antisera. As shown in Fig. 6, MAb
2B7 reacted strongly with all E. coli isolates possessing H7 and
did not react with any non-H7 antigens, except for H23 and
H24. The reactivity pattern of MAb 46E9-9 was very similar to
that of MAb 2B7 (data not shown). Polyclonal antisera from

ECRC and Difco Laboratories both also reacted with all E. coli
isolates possessing H7. However, both polyclonal antisera, in
particular the serum from Difco Laboratories, cross-reacted
with many non-H7 E. coli isolates. In fact, as shown in Fig. 6,
the ELISA cross-reactions of the polyclonal antisera to some
non-H7 E. coli isolates were even greater than their reactions
to H7 (e.g., antisera against H6 and H8 [Difco Laboratories]).
Both polyclonal anti-H7 sera, like the MAbs, also strongly
reacted with E. coli H23 and H24 bacteria.
DISCUSSION
This report describes the production and characterization of
two MAbs which are reactive against the E. coli H7 flagellar
antigen. A wide range of antigen preparations and techniques
were used first to select anti-H7 MAbs and then to define their
specificity. First, MAb reactivities against the E. coli H7 antigen were determined by indirect ELISA using whole-bacterium antigens. Of 216 whole-bacterium preparations, MAbs
2B7 and 46E9-9 were found to react strongly only to E. coli H7,
H23, and H24. The H7, H23, and H24 flagellin specificity of
the two MAbs was confirmed by indirect ELISA using partially
purified E. coli flagellins. The inhibition ELISA showed that
the partially purified H7 flagellin of E. coli O157:H7 efficiently
blocked binding of MAb 2B7 and MAb 46E9-9 to E. coli
O157:H7 whole-bacterium antigens. In addition, the flagellins
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FIG. 5. Competition ELISA for MAbs 2B7 and 46E9-9. ELISA plates were
coated with partially purified E. coli O157:H7 flagellin (10 mg/ml, 100 ml per
well). Unlabeled MAbs were then incubated at various concentrations on the
plates for 1 h at 378C. After washing, the test MAb labeled with HRPO was
added to wells and incubated for 10 min at 378C. ELISA reactivity is expressed
as mean OD (405 nm) of duplicate wells. The symbols represent the unlabeled
MAbs: E, 2B7; h, 46E9-9.

of E. coli O1:K1:H7, O45:H23, and O51:H24 also inhibited
MAb binding but with less efficiency compared with that of H7
flagellin of E. coli O157:H7. To further elucidate the epitope
specificities of the two MAbs, competition ELISA was performed with partially purified flagellin of E. coli O157:H7 as
the target antigen. MAbs 2B7 and 46E9-9 competed with equal
efficiencies in both homologous and heterologous manners,
suggesting that the two MAbs share the same or closely related
flagellar epitopes on E. coli H7. Western blotting permitted
visualization of the antigenic specificities of the two MAbs.
Interestingly, MAb 2B7 reacted strongly with E. coli H23, H24,
and H7 antigens from either O157:H7 or O1:K1:H7 by indirect
ELISA and Western blots. On the other hand, MAb 46E9-9
reacted strongly with E. coli H23, H24, and H7 antigens from
O157:H7 or O1:K1:H7 by indirect ELISA but reacted strongly
only with H7 from E. coli O157:H7 on Western blot. Immunoblots were run under protein-reducing conditions, while
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ELISAs were not. These findings suggest that MAb 46E9-9
may react with an epitope unique to the H7 antigen of E. coli
O157:H7, the nucleic acid and amino acid sequences of the H7
antigens of E. coli O157:H7 and O1:K1:H7 may not be identical, and the H7 epitope of E. coli O1:K1:H7 and the H23 and
H24 epitopes with which MAb 46E9-9 reacts may be conformational and not linear.
Serotyping of O and H antigens by agglutination using panels of individual or pooled preabsorbed polyclonal antisera has
been used to classify pathogenic E. coli and other enterobacteria for many years. However, the inadequacies of polyclonal
antisera for serotyping some enterobacteria have been reported (5). MAbs are not currently used for E. coli serotyping
in reference laboratories such as the ECRC but have the potential to serve as higher-quality immunodiagnostic reagents as
shown in this report. To our knowledge, only two polyclonal
anti-H7 sera are available commercially in the United States;
these antisera are used in several applications, including the
confirmatory H serotyping test for E. coli O157:H7 (36) and
motility determination for E. coli H7 isolates (6). On the basis
of the indirect ELISA technique described in this report, the
anti-H7 MAbs 2B7 and 46E9-9 are much more specific than
these two polyclonal anti-H7 antisera as measured against a
wide range of bacteria including E. coli O157:H7, E. coli nonO157:non-H7, Salmonella spp., and other gram-negative bacteria. MAbs 46E9-9 and 2B7 reacted against E. coli H7 without
cross-reactivity to other bacteria except for E. coli O45:H23
and O51:H24. In contrast, the anti-H7 serum from Difco Laboratories at a 1:8,000 dilution and the preabsorbed anti-H7
serum from the ECRC at a 1:2,000 dilution cross-reacted with
many non-O157:non-H7 E. coli isolates and even some non-E.
coli bacteria in the ELISA (Fig. 1). The patterns of lack of
MAb cross-reactivity and common polyclonal antisera crossreactivity were repeated when the antibodies were tested
against an antigen panel of 48 E. coli H serotypes (H1 to H56)
(Fig. 6). In addition to higher specificity, the MAbs also offer
the potential of a more standardized typing reagent compared
with polyclonal antisera.
Cross-reactivity makes differentiation among the H7, H23,
and H24 E. coli serotypes difficult whether polyclonal antisera
or our MAbs are used. Subtle relative differences in the microagglutination reactions between H7, H23, and H24 polyclonal antisera and the bacterial antigen are used by the ECRC
to serotype isolates among these three flagellar variants (39).
MAbs 2B7 and 46E9-9 reacted strongly with E. coli O45:H23
and O51:H24 in our indirect ELISA, using either whole-bacterial antigens or partially purified flagellins, as shown in Fig. 1,
2, and 6. The two polyclonal anti-H7 antisera also reacted
strongly with the H23 and H24 bacteria, as indicated in Fig. 1
and 6. However, inhibition ELISA and Western blot reactions
for MAb 46E9-9 (Fig. 3 and 4C) were strongest with H7 from
E. coli O157:H7 and weaker with H7 from O1:K1:H7 (the
reference H7 strain), H23, or H24. These data suggest that
MAb 46E9-9-defined differences may exist in the flagellin
structure among H7 isolates and between H7 and H23 or H24.
Since H antigenicity is dependent on the amino acid sequence
of the component flagellin protein, only minor nucleic or
amino acid compositional differences among E. coli H7, H23,
and H24 may define the specific serotypes. Our laboratory
recently compared flagellin gene and protein sequences between H7 from E. coli O157:H7 and H23 from E. coli O45:H23
(19). The H7 antigenic domain was localized to a 23-aminoacid sequence in the central variable region of the flagellin
gene. A single nucleotide difference between H7 and H23 was
found in this region, resulting in one amino acid substitution.
Additional comparative flagellin sequence and epitope map-
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FIG. 6. Comparison of ELISA reactivities of MAb 2B7 and two commercially available polyclonal anti-H7 antisera against E. coli H serotypes. ELISA plates were
coated with whole-bacterium antigens (50 mg/ml) of E. coli O157:H7, H7:non-O157, and 47 other H antigen serotypes. Diluted ascites fluid of MAb 2B7 (1:1,000),
preabsorbed rabbit polyclonal anti-H7 serum from ECRC (1:2,000), and polyclonal rabbit anti-H7 serum from Difco Laboratories (1:8,000) were incubated in duplicate
wells with the antigens for 10 min at 378C. After washing, HRPO-conjugated rabbit anti-mouse IgG and IgM antibody (KPL; 1:2,000) was added to MAb 2B7 plates
and HRPO-conjugated goat anti-rabbit IgG antibody (KPL; 1:2,000) was added to polyclonal antibody plates. ELISA reactivity is expressed as mean OD (405 nm) of
duplicate wells using the ABTS substrate.

ping among various H7 isolates, between H7 and H24 strains
and between H23 and H24 strains, may permit precise definition of these E. coli H antigen serotypes. In addition to serotyping, E. coli flagella have also been classified by surface
ultrastructural morphology into six principal groups (i.e., morphotypes A to F) (20). Interestingly, both E. coli H7 and H23
belong to the same morphotype (E), while H24 belongs to
morphotype C.
In conclusion, we have produced and characterized two
MAbs directed against the H7 flagellar antigen of E. coli.
These unique MAbs, whether used alone or in combination
with anti-O157-specific MAbs (which were also produced in
our laboratory), could be used for detection of the highly

pathogenic E. coli O157:H7 serotype in applications ranging
from meat or food inspection to medical specimen examination and research.
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